États-Unis · Plateformes & données · MarketBeat

Carlsmed (NASDAQ:CARL) Stock Price Target Raised at Truist Financial

Publié par MarketBeat · États-Unis il y a 34 min

Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

Truist Financial increased their price target on shares of Carlsmed from $20.00 to $23.00 and gave the company a "buy" rating in a research report on Wednesday.

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Carlsmed (NASDAQ:CARL) Stock Price Target Raised at Truist Financial

Résumé détaillé

À lire aussi

Talking Costco: Is the historic special dividend the right move?

Micron and other AI stocks surge as CoreWeave calms Wall Street’s worst fears

Stock Market Sell-Off: The 5 Best Stocks to Buy in November

Velaris at Stifel 2026 Healthcare Conference: betting on next-gen activin drugs

Best Stocks Under $5

Alibaba announces plans to list T-Head, its Nvidia chip rival

Carlsmed (NASDAQ:CARL) Stock Price Target Raised at Truist Financial

Résumé détaillé

Partager

À lire aussi

Talking Costco: Is the historic special dividend the right move?

Micron and other AI stocks surge as CoreWeave calms Wall Street’s worst fears

Stock Market Sell-Off: The 5 Best Stocks to Buy in November

Velaris at Stifel 2026 Healthcare Conference: betting on next-gen activin drugs

Best Stocks Under $5

Alibaba announces plans to list T-Head, its Nvidia chip rival